Login / Signup

Targeting the expression of T antigens with selinexor (KPT-330) shows promise for Merkel cell polyomavirus-positive Merkel cell carcinoma treatment.

Rohit GuptaR A SimonetteH Q DoanP L RadyS K Tyring
Published in: The British journal of dermatology (2021)
Keyphrases
  • poor prognosis
  • single cell
  • dendritic cells
  • cancer therapy
  • big data
  • binding protein
  • machine learning
  • bone marrow
  • long non coding rna
  • immune response
  • drug delivery
  • artificial intelligence